Evidence mapPaperPMID 40397989Full record

ArticleRheumatology (Oxford, England)2025

NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis.

Vafa Guliyeva, Fatma Gül Demirkan, Erdem Bektaş, Rabia Deniz, Zeliha Emrence, Özlem Akgün, Selen Duygu Arık, Ayşenur Doğru, Ayşe Tanatar, Neslihan Abacı and 3 more

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vafa GuliyevaDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0002-1663-015X
Fatma Gül DemirkanDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0001-9950-2489
Erdem BektaşDepartment of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.ORCID 0000-0002-1348-4118
Rabia DenizDepartment of Rheumatology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.ORCID 0000-0003-4537-894X
Zeliha EmrenceDepartment of Genetics, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.ORCID 0000-0003-4809-6366
Özlem AkgünDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0001-7216-0562
Selen Duygu ArıkDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0001-7648-1195
Ayşenur DoğruDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0001-8091-8417
Ayşe TanatarDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0002-1386-4575
Neslihan AbacıDepartment of Genetics, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.ORCID 0000-0002-9962-4010
Sema Sırma EkmekciDepartment of Genetics, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.ORCID 0000-0002-1201-7542
Ahmet GülDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.ORCID 0000-0001-8219-3720
Nuray Aktay AyazDepartment of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0003-3594-7387

Funding

Istanbul University Scientific Research Projects Coordination Unit TSA-2023-39657
6 · The paper itself

Abstract

objectivesThe role of neutrophil extracellular traps (NETs) in IgA vasculitis (IgAV) pathogenesis is emerging, with NETosis-associated markers potentially linked to disease activity. This study aimed to explore the relationship between NETosis biomarkers and IgAV disease phases.

methodsA longitudinal study involving 33 paediatric IgAV patients and 26 healthy controls was conducted. Blood and urine samples were collected from healthy controls and patients during active and inactive disease phases. NETosis markers, including cell-free DNA (cf-DNA), neutrophil elastase, MPO and citrullinated histone H3 (cit-H3) were measured using ELISA kits. Statistical analyses were conducted to compare differences for NETosis markers between groups and to evaluate correlations among variables using appropriate statistical tests.

resultsThere was no significant difference in gender and age between the patient and control groups. The serum cf-DNA level was significantly higher in the active patient group compared with the control and inactive patient groups (P = 0.04; P = 0.04, respectively). In urine, MPO levels were significantly lower in the active phase of patients than controls (P = 0.009), while cit-H3 levels were higher in both active and inactive phases compared with controls (P = 0.01 and P = 0.03, respectively). A cf-DNA threshold of 935 ng/ml was identified, which achieved a sensitivity of 93% (correctly identifying 93% of active patients) and a specificity of 72% (correctly identifying 72% of healthy controls).

conclusionElevated serum cf-DNA and urine cit-H3 suggest a potential role for NETosis in IgAV activity, highlighting these markers as potential indicators for disease monitoring. Further studies are warranted to establish standardized protocols for NETosis marker assessment in IgAV.

Indexed as

Extracellular TrapsIgA VasculitisAdolescentBiomarkersCase-Control StudiesCell-Free Nucleic AcidsChildFemaleHistonesHumansImmunoglobulin ALeukocyte ElastaseLongitudinal StudiesMalePeroxidaseBiomarkersCell-Free Nucleic AcidsHistonesImmunoglobulin ALeukocyte ElastasePeroxidasebiomarkersimmunoglobulin A vasculitisneutrophil extracellular traps (NETosis)

Identifiers

PMID40397989
PMCPMC12494227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.